Your browser doesn't support javascript.
loading
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation.
Saulite, Ieva; Ignatova, Desislava; Chang, Yun-Tsan; Fassnacht, Christina; Dimitriou, Florentia; Varypataki, Eleni; Anzengruber, Florian; Nägeli, Mirjam; Cozzio, Antonio; Dummer, Reinhard; Scarisbrick, Julia; Pascolo, Steve; Hoetzenecker, Wolfram; Bobrowicz, Malgorzata; Guenova, Emmanuella.
Afiliação
  • Saulite I; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Ignatova D; Department of Dermatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Chang YT; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Fassnacht C; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Dimitriou F; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Varypataki E; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Anzengruber F; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Nägeli M; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Cozzio A; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Dummer R; Department of Dermatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Scarisbrick J; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Pascolo S; Department of Dermatology, University Hospitals Birmingham, Birmingham, UK.
  • Hoetzenecker W; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Bobrowicz M; Department of Dermatology, Kepler University Hospital, Linz, Austria.
  • Guenova E; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
Oncoimmunology ; 9(1): 1738797, 2020.
Article em En | MEDLINE | ID: mdl-32760603
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Receptor de Morte Celular Programada 1 Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Receptor de Morte Celular Programada 1 Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça